28 min

SGLT2 Inhibitors in the Post-Myocardial Infarction Population: Answering the Last Unanswered Question Keeping Current

    • Medicine

Are you ready to answer the last remaining question in sodium-glucose co-transporter 2 (SGLT2) inhibitor therapy for heart failure (HF)?
  
Credit available for this activity expires: 5/13/2024
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000749?ecd=bdc_podcast_libsyn_mscpedu

Are you ready to answer the last remaining question in sodium-glucose co-transporter 2 (SGLT2) inhibitor therapy for heart failure (HF)?
  
Credit available for this activity expires: 5/13/2024
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000749?ecd=bdc_podcast_libsyn_mscpedu

28 min

More by Medscape

This Week in Cardiology
Medscape
Medicine and the Machine
Medscape
One-on-One with Eric Topol
Medscape
Keeping Current CME
Medscape
Keeping Current
Medscape Podcasts
The Bob Harrington Show
Medscape